$IBB Recent News Stocks suffer big weekly loss; Nasdaq

New Post Public Reply Private Reply Replies (0) Message Board

Apr 12, 2014 at 10:31 AM

$IBB Recent News

Stocks suffer big weekly loss; Nasdaq below 4,000 5:45 p.m. April 11, 2014 - Victor Reklaitis
Carnage continues for biotechs as bears set up camp 5:30 p.m. April 11, 2014 - blogs.marketwatch.com
Stock market live blog: Nasdaq drops to 4,000; stocks lose 1% 4:02 p.m. April 11, 2014 - blogs.marketwatch.com
Biotech stocks flirt with bear territory as shares, ETFs falling down again 10:29 a.m. April 11, 2014 - blogs.marketwatch.com
Nasdaq pummeled in worst day since 2011 as tech, biotech cave (Stock market live blog recap) 4:53 p.m. April 10, 2014 - blogs.marketwatch.com
U.S. stock market hit by Nasdaq, biotech rout 4:40 p.m. April 10, 2014 - Anora Mahmudova
This stock market needs a correction 4:04 p.m. April 10, 2014 - Jonathan Burton
Biotech hammered as ETFs down 5%, while some stocks fall 10% 1:55 p.m. April 10, 2014 - blogs.marketwatch.com
Don’t let these stock market gyrations scare you 6:15 a.m. April 10, 2014 - Howard Gold
Tesla-Facebook pain trade shifts focus to value stocks 4:39 p.m. April 9, 2014 - William L. Watts
S&P 500 nabs best gain in a month as Fed reassures: stock market live blog recap 3:57 p.m. April 9, 2014 - blogs.marketwatch.com
Investors too worried about tech's tumble, spoiled by low volatility: Citi 2:11 p.m. April 9, 2014 - blogs.marketwatch.com
Is biotech caught in a bubble, and is it popping? 1:13 p.m. April 8, 2014 - Russ Britt
Patience pays 5:24 p.m. April 7, 2014 - Bill Donoghue
Stocks fall for 3rd day in row; S&P 500 down for year again: stock market live blog recap 4:11 p.m. April 7, 2014 - blogs.marketwatch.com
Charting the SPY’s key reversal 11:31 a.m. April 7, 2014 - Michael Ashbaugh
How sector stock funds can make your portfolio whole 7:01 a.m. April 7, 2014 - Jonathan Burton
That screeching sound is the market losing momentum 8:59 p.m. April 6, 2014 - Dave Fry
U.S. stocks sell off; Nasdaq drop worst in 2 months 4:43 p.m. April 4, 2014 - Anora Mahmudova
3 red-hot investment opportunities 8:40 a.m. April 3, 2014 - Jeff Reeves

'Fast Money' Recap: The Skid Continues 5:00 a.m. Today - TheStreet.com
Riding the Tech Roller Coaster 7:06 p.m. April 11, 2014 - The Wall Street Journal Interactive Edition
Biotech Rout Not Surprising: Surveying The Damage 4:22 p.m. April 11, 2014 - Seeking Alpha
Today's Market: Playing The Biotech Bloodbath 10:49 a.m. April 11, 2014 - Seeking Alpha
Jim Cramer's Mad Dash: HRB GILD 10:38 a.m. April 11, 2014 - TheStreet.com
Inside the Wild Ride of Biotech ETFs - ETF News And Commentary 10:01 a.m. April 11, 2014 - Zacks.com
3 Biotech Stocks That Could Keep Bombing 4:27 a.m. April 11, 2014 - InvestorPlace.com
Momentum stocks collapse as Nasdaq posts worst loss since 2011 4:25 p.m. April 10, 2014 - Seeking Alpha
Biotechs don't have a friend in sight 3:03 p.m. April 10, 2014 - Seeking Alpha
Oh Biotech, You Are a Cruel Bitch 1:09 p.m. April 10, 2014 - TheStreet.com
Nasdaq Pummeled as Trouble in Asia Escalates 12:34 p.m. April 10, 2014 - InvestorPlace.com
Changing Winds for the Stock Market’s Leaders 11:55 a.m. April 10, 2014 - InvestorPlace.com
Momentum names tumbling again 11:09 a.m. April 10, 2014 - Seeking Alpha
The Words Go Round And Round 6:31 a.m. April 10, 2014 - Seeking Alpha
It’s Best to Hold Cash in This Perplexing Market 9:51 p.m. April 9, 2014 - InvestorPlace.com
Bubble Bursting? Only For Biotech And Internet Stocks 6:22 p.m. April 9, 2014 - Seeking Alpha
Biotech Stocks Have Enormous Upside 4:00 p.m. April 9, 2014 - RealMoney.com
Jazz Pharma: Risk 1% Downside, 34% Upside To Fair Value 12:17 p.m. April 9, 2014 - Seeking Alpha
Jazz Pharma: Risk 7% Downside, 34% Upside To Fair Value 12:17 p.m. April 9, 2014 - Seeking Alpha
Your Best Best for Value: Emerging Markets 6:54 a.m. April 9, 2014 - InvestorPlace.com

OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 9:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 9:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 9:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 6:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 8:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 8:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 8:00 a.m. Dec. 17, 2013 - GlobeNewswire
Annual Changes to the NASDAQ Biotechnology Index 9:05 a.m. Dec. 16, 2013 - GlobeNewswire
Galectin Stands Out in 2013 with Liver Fibrosis Drug 12:06 p.m. Oct. 14, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARRY, GNVC, IDIX and NVAX 9:02 a.m. Sept. 16, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ARIA, ARNA, EXEL and OREX 9:05 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTX, GALT, IMMU and OXBT 8:52 a.m. Sept. 11, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACHN, BLRX, DSCO and ONCY 8:51 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP 8:41 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on DNDN, HALO, MNKD and PDLI 8:30 a.m. Sept. 10, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on GILD, ITMN, MDVN and PBYI 9:01 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ALXN, AMGN, CBST and CLDX 8:50 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on BIIB, CYTK, ISIS and SRPT 8:40 a.m. Sept. 6, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on ANAC, RPRX, THLD and THRX 8:52 a.m. July 17, 2013 - ACCESSWIRE
Wall Street Fundamentals Releases New In-Depth Stock Reports on CYTK, DNDN, IMGN and NVAX 8:43 a.m. July 17, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

IM Cannabis's Third Quarter Financial Jolt

By Caleb Price Updated Nov 13, 2026 Category News Views 120

IM Cannabis Takes a Hit, But Seeks New Angles Diving into IM Cannabis's (NASDAQ: IMCC) latest financial splash is like reading a weathered old map of the stock market. The third quarter of 2026 wasn't kind to this little cannabis outfit. Revenues have nosedived to C$1.65 million from last year's C$5.08 million. It's not just the typical bad quarter blues; it's a solid...

MV Transportation Celebrates Leadership Nomination for FTA

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Enjay Acquires New Method: A Strategic Synergy Unfolds

Enjay's Bold Move into New Territory Here's a headline that doesn’t just flutter past like yesterday's news. Enjay Converters Ltd, straight from Cobourg, Ontario, has clinched a deal that looks like it might just shake things up a bit on the food packaging scene. They’ve bagged New Method Packaging LLC, another big player, but this time from the heartland of...

Microsoft's Cloud Misstep: Recovery Plans in Focus

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Hybrid Bonding Market Shooting to $2.45 Billion by 2033

Hybrid Bonding: The Future of Semiconductor Interconnects? Mark these words: Hybrid bonding isn't just another tech trend—it’s morphing into a billion-dollar juggernaut, my friend. With the latest numbers from MarketsandMarkets™, we see a potential leap from USD 0.38 billion in 2026 to a staggering USD 2.45 billion by 2033. We'll be seeing an eye-popping CAGR of...

Sino Bio Speeds AI Drug Discovery with 4RISE Launch

AI Meets Real-World Validation In the world of cutting-edge biotech, Sino Biological is turning heads with its latest move. If you're in the game of AI-driven drug discovery, their new 4RISE™ high-throughput wet-lab validation services could be the breakthrough you've been waiting for. Why? Well, the promise of AI is dazzling, but it all boils down to how fast you can...

NVIDIA Faces Legal Turbulence: CEO's Exit Sparks Chaos

Jensen Huang's Sudden Exit: A Barrage of Headlines In what feels like a blow delivered by a sledgehammer, NVIDIA is rocked by the abrupt resignation of its iconic co-founder and CEO, Jensen Huang. This isn't some quiet departure into the night. Nope, it's more like a cannonball being fired into the investor lounge, leaving a wreckage for all to navigate through. Huang's...

Nonprofit and Partners Gift Homes to Veterans

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

BETR Investors Face Action: Nov. 20 Deadline Nears

High Stakes for BETR Shareholders If you're holding shares in Better Home & Finance Holding Company, right now might feel like you're at a craps table with emptying pockets. BETR, trading under NASDAQ, has become the center of a legal hurricane, with investors eyeing the November 20th deadline to join a securities class action led by Hagens Berman. The class period in...

Philip Scroggie's Legacy in Global Energy Projects

A Lifetime of Energy Industry Excellence When you've been around the block in the energy sector as long as Philip D. Scroggie has, you're bound to pick up a few accolades. Recognized as an Inner Circle Lifetime Member, this guy has etched his name in the annals of global energy project management. Yeah, he's been a heavyweight in the oil, gas, and LNG industries, and he's...